3D bioprinting for high-throughput screening: Drug screening, disease modeling, and precision medicine applications

Applied Physics Reviews - Tập 6 Số 1 - 2019
Andrea Mazzocchi1,2,3,4, Shay Söker5,6,3,4, Aleksander Skardal5,6,3,4
13Comprehensive Cancer Center at Wake Forest Baptist Medical, Medical Center Boulevard, Winston-Salem, North Carolina 27157, USA
24Department of Cancer Biology, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, North Carolina 27157, USA
3Virginia Tech-Wake Forest School of Biomedical Engineering and Sciences, Wake Forest School of Medicine, Medical Center Boulevard 2 , Winston-Salem, North Carolina 27157, USA
4Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Medical Center 1 , Winston-Salem, North Carolina 27101, USA
5Comprehensive Cancer Center at Wake Forest Baptist Medical, Medical Center Boulevard 3 , Winston-Salem, North Carolina 27157, USA
6Department of Cancer Biology, Wake Forest School of Medicine, Medical Center Boulevard 4 , Winston-Salem, North Carolina 27157, USA

Tóm tắt

High-throughput technologies have become essential in many fields of pharmaceutical and biological development and production. Such technologies were initially developed with compatibility with liquid handling-based cell culture techniques to produce large-scale 2D cell culture experiments for the compound analysis of candidate drug compounds. Over the past two decades, tools for creating 3D cell cultures, organoids, and other 3D in vitro models, such as cell supportive biomaterials and 3D bioprinting, have rapidly advanced. Concurrently, a significant body of evidence has accumulated which speaks to the many benefits that 3D model systems have over traditional 2D cell cultures. Specifically, 3D cellular models better mimic aspects such as diffusion kinetics, cell-cell interactions, cell-matrix interactions, inclusion of stroma, and other features native to in vivo tissue and as such have become an integral part of academic research. However, most high throughput assays were not developed to specifically support 3D systems. Here, we describe the need for improved compatibility and relevant advances toward deployment and adoption of high throughput 3D models to improve disease modeling, drug efficacy testing, and precision medicine applications.

Từ khóa


Tài liệu tham khảo

2000, High-throughput screening in drug metabolism and pharmacokinetic support of drug discovery, Annu. Rev. Pharmacol. Toxicol., 40, 133, 10.1146/annurev.pharmtox.40.1.133

2015, Liver-tumor hybrid organoids for modeling tumor growth and drug response in vitro, Ann. Biomed. Eng., 43, 2361, 10.1007/s10439-015-1298-3

2011, High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array, Analyst, 136, 473, 10.1039/C0AN00609B

2013, Three-dimensional cell culture: The missing link in drug discovery, Drug Discovery Today, 18, 240, 10.1016/j.drudis.2012.10.003

2007, Origin and evolution of high throughput screening, Br. J. Pharmacol., 152, 53, 10.1038/sj.bjp.0707373

2010, Predictors of a true complete response among disappearing liver metastases from colorectal cancer after chemotherapy, Cancer, 116, 1502, 10.1002/cncr.24912

2018, Applications of bioengineered 3D tissue and tumor organoids in drug development and precision medicine: Current and future, BioDrugs, 32, 53, 10.1007/s40259-017-0258-x

2007, The third dimension bridges the gap between cell culture and live tissue, Nat. Rev. Mol. Cell Biol., 8, 839, 10.1038/nrm2236

2016, Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling, Drug Discovery Today, 21, 1399, 10.1016/j.drudis.2016.07.003

2013, Impact of the 3D microenvironment on phenotype, gene expression, and EGFR inhibition of colorectal cancer cell lines, PLoS One, 8, e59689, 10.1371/journal.pone.0059689

2013, Multi-cell type human liver microtissues for hepatotoxicity testing, Arch. Toxicol., 87, 209, 10.1007/s00204-012-0968-2

2014, Critical analysis of 3-D organoid in vitro cell culture models for high-throughput drug candidate toxicity assessments, Adv. Drug Delivery Rev., 69–70, 1, 10.1016/j.addr.2014.02.008

2017, Mesenchymal stem cells support growth and organization of host-liver colorectal-tumor organoids and possibly resistance to chemotherapy, Biofabrication, 9, 021002, 10.1088/1758-5090/aa7484

2010, Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells, Biomaterials, 31, 8494, 10.1016/j.biomaterials.2010.07.064

2006, Micromolding of photocrosslinkable chitosan hydrogel for spheroid microarray and co-cultures, Biomaterials, 27, 5259, 10.1016/j.biomaterials.2006.05.044

2012, Controlled formation of heterotypic hepatic micro-organoids in anisotropic hydrogel microfibers for long-term preservation of liver-specific functions, Biomaterials, 33, 8304, 10.1016/j.biomaterials.2012.07.068

2012, Tissue specific synthetic ECM hydrogels for 3-D in vitro maintenance of hepatocyte function, Biomaterials, 33, 4565, 10.1016/j.biomaterials.2012.03.034

2013, The independent roles of mechanical, structural and adhesion characteristics of 3D hydrogels on the regulation of cancer invasion and dissemination, Biomaterials, 34, 9486, 10.1016/j.biomaterials.2013.08.077

2009, Complexity in biomaterials for tissue engineering, Nat. Mater., 8, 457, 10.1038/nmat2441

2009, Hydrogels as extracellular matrix mimics for 3D cell culture, Biotechnol. Bioeng., 103, 655, 10.1002/bit.22361

2017, Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform, Sci. Rep., 7, 8837, 10.1038/s41598-017-08879-x

2014, 3D bioprinting of tissues and organs, Nat. Biotechnol., 32, 773, 10.1038/nbt.2958

2006, Review: Bioprinting: A beginning, Tissue Eng., 12, 631, 10.1089/ten.2006.12.631

2016, A 3D bioprinting system to produce human-scale tissue constructs with structural integrity, Nat. Biotechnol., 34, 312, 10.1038/nbt.3413

2015, Microfluidic organ/body-on-a-chip devices at the convergence of biology and microengineering, Sensors(Basel), 15, 31142, 10.3390/s151229848

2015, Dynamic phototuning of 3D hydrogel stiffness, Proc. Natl. Acad. Sci. U. S. A., 112, 1953, 10.1073/pnas.1421897112

2018, Advanced development of primary pancreatic organoid tumor models for high-throughput phenotypic drug screening, SLAS Discovery, 23, 574, 10.1177/2472555218766842

2013, High-throughput printing via microvascular multinozzle arrays, Adv. Mater., 25, 96, 10.1002/adma.201203321

2011, A three-dimensional in vitro ovarian cancer coculture model using a high-throughput cell patterning platform, Biotechnol. J., 6, 204, 10.1002/biot.201000340

2013, Laser assisted cell printing, Curr. Pharm. Biotechnol., 14, 91, 10.2174/138920113804805368

2010, High-throughput laser printing of cells and biomaterials for tissue engineering, Acta Biomater., 6, 2494, 10.1016/j.actbio.2009.09.029

2010, Laser-assisted cell printing: Principle, physical parameters versus cell fate and perspectives in tissue engineering, Nanomedicine (London), 5, 507, 10.2217/nnm.10.14

2016, Drop-on-demand inkjet-based cell printing with 30-μm nozzle diameter for cell-level accuracy, Biomicrofluidics, 10, 064110, 10.1063/1.4968845

2017, Rapid continuous multimaterial extrusion bioprinting, Adv. Mater., 29, 1604630, 10.1002/adma.201604630

2015, A hydrogel bioink toolkit for mimicking native tissue biochemical and mechanical properties in bioprinted tissue constructs, Acta Biomater., 25, 24, 10.1016/j.actbio.2015.07.030

2016, Current advances and future perspectives in extrusion-based bioprinting, Biomaterials, 76, 321, 10.1016/j.biomaterials.2015.10.076

2014, Direct-write bioprinting of cell-laden methacrylated gelatin hydrogels, Biofabrication, 6, 024105, 10.1088/1758-5082/6/2/024105

2016, Microfluidic bioprinting of heterogeneous 3D tissue constructs using low-viscosity bioink, Adv. Mater., 28, 677, 10.1002/adma.201503310

2015, A novel bioprinting method and system for forming hybrid tissue engineering constructs, Biofabrication, 7, 045008, 10.1088/1758-5090/7/4/045008

2013, Cellular behavior in micropatterned hydrogels by bioprinting system depended on the cell types and cellular interaction, J. Biosci. Bioeng., 116, 224, 10.1016/j.jbiosc.2013.02.011

2015, Three-dimensional printing of complex biological structures by freeform reversible embedding of suspended hydrogels, Sci. Adv., 1, e1500758, 10.1126/sciadv.1500758

2018, Engineering innervated secretory epithelial organoids by magnetic three-dimensional bioprinting for stimulating epithelial growth in salivary glands, Biomaterials, 180, 52, 10.1016/j.biomaterials.2018.06.011

2018, 3D bioprinting of functional tissue models for personalized drug screening and in vitro disease modeling, Adv. Drug Delivery Rev., 132, 235, 10.1016/j.addr.2018.06.011

2015, Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer, Oncol. Rep., 33, 1837, 10.3892/or.2015.3767

2014, A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies, Arch. Toxicol., 88, 1083, 10.1007/s00204-014-1215-9

2016, A reductionist metastasis-on-a-chip platform for in vitro tumor progression modeling and drug screening, Biotechnol. Bioeng., 113, 2020, 10.1002/bit.25950

2014, A three-dimensional human neural cell culture model of Alzheimer's disease, Nature, 515, 274, 10.1038/nature13800

2009, 3D cell culture opens new dimensions in cell-based assays, Drug Discovery Today, 14, 102, 10.1016/j.drudis.2008.11.006

2011, Remodeling and homeostasis of the extracellular matrix: Implications for fibrotic diseases and cancer, Dis. Models Mech., 4, 165, 10.1242/dmm.004077

2007, Engineering the stem cell microenvironment, Biotechnol. Prog., 23, 18, 10.1021/bp060350a

2015, Modes of cancer cell invasion and the role of the microenvironment, Curr. Opin. Cell Biol., 36, 13, 10.1016/j.ceb.2015.06.004

2011, From 3D cell culture to organs-on-chips, Trends Cell Biol., 21, 745, 10.1016/j.tcb.2011.09.005

2015, Hydrogel: Preparation, characterization, and applications: A review, J. Adv. Res., 6, 105, 10.1016/j.jare.2013.07.006

2016, Bioink properties before, during and after 3D bioprinting, Biofabrication, 8, 032002, 10.1088/1758-5090/8/3/032002

2017, The bioink: A comprehensive review on bioprintable materials, Biotechnol. Adv., 35, 217, 10.1016/j.biotechadv.2016.12.006

2013, Evaluation of hydrogels for bio-printing applications, J. Biomed. Mater. Res., Part A, 101, 272, 10.1002/jbm.a.34326

2015, Biomaterials for integration with 3-D bioprinting, Ann. Biomed. Eng., 43, 730, 10.1007/s10439-014-1207-1

2015, To cross-link or not to cross-link? Cross-linking associated foreign body response of collagen-based devices, Tissue Eng., Part B, 21, 298, 10.1089/ten.teb.2014.0290

2017, A generalizable strategy for the 3D bioprinting of hydrogels from nonviscous photo-crosslinkable inks, Adv. Mater., 29, 1604983, 10.1002/adma.201604983

2011, Elucidating the role of matrix stiffness in 3D cell migration and remodeling, Biophys. J., 100, 284, 10.1016/j.bpj.2010.11.082

2016, Advanced bioinks for 3D printing: A materials science perspective, Ann. Biomed. Eng., 44, 2090, 10.1007/s10439-016-1638-y

2017, Synthetic hydrogels for human intestinal organoid generation and colonic wound repair, Nat. Cell Biol., 19, 1326, 10.1038/ncb3632

2018, RGD-functionalized polyethylene glycol hydrogels support proliferation and in vitro chondrogenesis of human periosteum-derived cells, J. Biomed. Mater. Res., Part A, 106, 33, 10.1002/jbm.a.36208

2015, Peptide hydrogels - Versatile matrices for 3D cell culture in cancer medicine, Front. Oncol., 5, 92, 10.3389/fonc.2015.00092

2010, Reconstituting organ-level lung functions on a chip, Science, 328, 1662, 10.1126/science.1188302

2012, Microengineered physiological biomimicry: Organs-on-chips, Lab Chip, 12, 2156, 10.1039/c2lc40089h

2014, Physiologically relevant organs on chips, Biotechnol. J., 9, 16, 10.1002/biot.201300187

2009, The extracellular matrix: Not just pretty fibrils, Science, 326, 1216, 10.1126/science.1176009

2014, Remodelling the extracellular matrix in development and disease, Nat. Rev. Mol. Cell Biol., 15, 786, 10.1038/nrm3904

2014, Printing three-dimensional tissue analogues with decellularized extracellular matrix bioink, Nat. Commun., 5, 3935, 10.1038/ncomms4935

2016, Bioprinting cellularized constructs using a tissue-specific hydrogel bioink, J. Visualized Exp., 110, e53606, 10.3791/53606

2007, Cell spreading and focal adhesion dynamics are regulated by spacing of integrin ligands, Biophys. J., 92, 2964, 10.1529/biophysj.106.089730

2005, Differential regulation of osteoblasts by substrate microstructural features, Biomaterials, 26, 1837, 10.1016/j.biomaterials.2004.06.035

2009, Endothelial actin and cell stiffness is modulated by substrate stiffness in 2D and 3D, J. Biomech., 42, 1114, 10.1016/j.jbiomech.2009.02.012

2006, Matrix elasticity directs stem cell lineage specification, Cell, 126, 677, 10.1016/j.cell.2006.06.044

2014, Interplay of matrix stiffness and protein tethering in stem cell differentiation, Nat. Mater., 13, 979, 10.1038/nmat4051

2011, The role of body-on-a-chip devices in drug and toxicity studies, Annu. Rev. Biomed. Eng., 13, 55, 10.1146/annurev-bioeng-071910-124629

2000, Lab-on-a-chip: A revolution in biological and medical sciences, Anal. Chem., 72, 330A, 10.1021/ac002800y

2012, Drug discovery in pharmaceutical industry: Productivity challenges and trends, Drug Discovery Today, 17, 1088, 10.1016/j.drudis.2012.05.007

2013, A high-throughput three-dimensional cell migration assay for toxicity screening with mobile device-based macroscopic image analysis, Sci. Rep., 3, 3000, 10.1038/srep03000

2016, miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer, Oncotarget, 7, 25930, 10.18632/oncotarget.8412

2017, Drug metabolism in the liver, Clin. Liver Dis., 21, 1, 10.1016/j.cld.2016.08.001

2006, Human hepatocyte transplantation: Worldwide results, Transplantation, 82, 441, 10.1097/01.tp.0000231689.44266.ac

2014, In vitro platforms for evaluating liver toxicity, Exp. Biol. Med. (Maywood), 239, 1180, 10.1177/1535370214531872

2016, Bioprinted 3D primary liver tissues allow assessment of organ-level response to clinical drug induced toxicity in vitro, PLoS One, 11, e0158674, 10.1371/journal.pone.0158674

2015, Bioprinting of human pluripotent stem cells and their directed differentiation into hepatocyte-like cells for the generation of mini-livers in 3D, Biofabrication, 7, 044102, 10.1088/1758-5090/7/4/044102

2016, Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting, Proc. Natl. Acad. Sci. U. S. A., 113, 2206, 10.1073/pnas.1524510113

2014, Light-assisted direct-write of 3D functional biomaterials, Lab Chip, 14, 268, 10.1039/C3LC50634G

2017, Three-dimensional bio-printing: A new frontier in oncology research, World J. Clin. Oncol., 8, 21, 10.5306/wjco.v8.i1.21

2015, 3-Dimensional bioprinting makes its mark: New tissue and organ printing methods are yielding critical new tools for the laboratory and clinic, Cancer Cytopathol., 123, 203, 10.1002/cncy.21543

2017, 3D bioprinting for drug discovery and development in pharmaceutics, Acta Biomater., 57, 26, 10.1016/j.actbio.2017.05.025

2015, Precision medicine for cancer with next-generation functional diagnostics, Nat. Rev. Cancer, 15, 747, 10.1038/nrc4015

2015, Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases, Proc. Natl. Acad. Sci. U. S. A., 112, 13308, 10.1073/pnas.1516689112

2018, In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening, Sci. Rep., 8, 2886, 10.1038/s41598-018-21200-8

2015, A new initiative on precision medicine, N. Engl. J. Med., 372, 793, 10.1056/NEJMp1500523

2015, Precision medicine–personalized, problematic, and promising, N. Engl. J. Med., 372, 2229, 10.1056/NEJMsb1503104

2013, Next-generation regenerative medicine: Organogenesis from stem cells in 3D culture, Cell Stem Cell, 12, 520, 10.1016/j.stem.2013.04.009

2011, Harnessing the potential of induced pluripotent stem cells for regenerative medicine, Nat. Cell Biol., 13, 497, 10.1038/ncb0511-497

2007, Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens, Circulation, 115, 896, 10.1161/CIRCULATIONAHA.106.655209

2017, Human periosteal-derived cell expansion in a perfusion bioreactor system: Proliferation, differentiation and extracellular matrix formation, J. Tissue Eng. Regener. Med., 11, 519, 10.1002/term.1951

2017, Optimizing human induced pluripotent stem cell expansion in stirred-suspension culture, Stem Cells Dev., 26, 1804, 10.1089/scd.2017.0090

2011, Scalable expansion of human pluripotent stem cells in suspension culture, Nat. Protoc., 6, 689, 10.1038/nprot.2011.318